Cancer in Primary Care Research

PRESIDE Trial Participation

This CPD is part of the PRESIDE Trial. Further information on the trial is available here. As part of this CPD GPs will be able to contribute to research and reflect on their own practice. We will cover consideration of the PGx information when determining the best avenue for treatment of patients’ depressive symptoms (pharmacological or non-pharmacological), as well as follow-up of that patient’s side effects and symptoms. GPs will be provided with a summary of the consultations they have had with the patients enrolled in the trial, in the 6-month follow-up period. This is an opportunity for reflection about the role of PGx testing in their management of depression and their management of mental health generally. Participants can also review the full PGx report and reflect on its potential use in prescribing generally.

RACGP CPD Approved.

CPD Hours

Education Activity: 1
Reviewing Performance: 5
Monitoring Outcomes: 6

Total Hours: 6

Delivery mode: Blended

Availability: By invitation only

Target audience
GPs

How to Enrol/More information
CPD activity only avaliable to GPs participating in the PRESIDE trial. Click here for further information.

PRESIDE GP Qualitative Interviews

Qualitative interviews with education and reflective component for the PRESIDE Trial.

RACGP CPD Approved.

CPD Hours

Education Activity: 0.5
Reviewing Performance: 1.5
Monitoring Outcomes: 0

Total Hours: 2

Delivery mode: Blended

Frequency: Time limited- June 2023 onwards

Availability: By invitation only

Target audience
GPs

How to Enrol/More information
Click here for further information.

IC3 Trial

CPD points are allocated to GP's for participation in the IC3 Trial. This trial will determine if a new cirrhosis detection pathway for liver disease is a feasible and cost effective program, which should be implemented nationally. GP's will take part in an introductory trial information session and will be asked to review patients suitable for the trial. They will be asked to review incidental blood findings and make appropriate referrals to liver specialists during this trial. This trial offers a significant degree of self reflection on current practice of liver health care and all participating GP's will receive and review trial related results at trial end. Participation may affect how they perceive, manage and treat patients in the future, with risk factors for chronic liver disease.

RACGP CPD and ACRRM CPD Approved.

Click here for further information.